Skip to main content

10 Result(s)

within C. J. Rodenburg Remove this filter

and

  1. Article

    Open Access

    Cancer survivors’ needs during various treatment phases after multimodal treatment for colon cancer - is there a role for eHealth?

    More colon cancer patients are expected to fully recover after treatment due to earlier detection of cancer and improvements in general health- and cancer care. The objective of this study was to gather partic...

    C. M. den Bakker, F. G. Schaafsma, J. A. F. Huirne, E. C. J. Consten… in BMC Cancer (2018)

    Download PDF (1751 KB) View Article

  2. No Access

    Article

    Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

    An increased dose-intensity can be achieved by either higher dose of chemotherapy per cycle (dose-escalation) or by shortening the interval between cycles (dose-dense). This multicenter randomized phase II stu...

    R. I. Lalisang, F. L. G. Erdkamp, C. J. Rodenburg… in Breast Cancer Research and Treatment (2011)

  3. No Access

    Chapter

    Oncologie

    In dit hoofdstuk, waarin solide tumoren worden besproken, wordt eerst kort ingegaan op de epidemiologie en etiologie. Vervolgens komen algemene aspecten van diagnostiek, stagering en therapie aan de orde.

    E.G.E. de Vries, A.K.L. Reyners, C.J. Rodenburg, P.H.B. Willemse… in Interne geneeskunde (2007)

  4. No Access

    Article

    Venous thrombosis as a complication of antiemetic treatment

    P. H. T. J. Slee, C. J. Rodenburg in Cancer Chemotherapy and Pharmacology (1996)

  5. No Access

    Article

    The effects of an ACTH (4–9) analogue on development of cisplatin neuropathy in testicular cancer: A randomized trial

    The efficacy of the ACTH (4–9) analogue Org 2766 in the prevention of subclinical cisplatin neuropathy was assessed in a double-blind placebo-controlled multi-centre study in patients with testicular cancer or...

    J. M. A. van Gerven, A. Hovestadt, J. W. B. Moll, C. J. Rodenburg… in Journal of Neurology (1994)

  6. No Access

    Article

    Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer

    Weekly low dose mitoxantrone (3 mg/m2) plus doxorubicin (8 mg/m2) was administered as second-line chemotherapy to 33 patients with advanced breast cancer. Four out of 28 evaluable patients (14%) obtained a partia...

    M. Bontenbal, A. S. Th. Planting, C. J. Rodenburg… in Breast Cancer Research and Treatment (1992)

  7. No Access

    Article

    Occurrence of epidermal growth factor receptors in benign and malignant ovarian tumors and normal ovarian tissues: an immunohistochemical study

    Epidermal growth factor receptor (EGF-R) was studied with monoclonal antibody 2E9 on 50 ovarian tumors of various histological types and 10 non-tumorous ovarian tissues by immunohistochemistry. Enhanced expres...

    S. C. Henzen-Logmans, M. E. L. van der Burg… in Journal of Cancer Research and Clinical On… (1992)

  8. No Access

    Chapter

    Chemotherapy

    The history of cancer chemotherapy started with the incidental discovery that nitrogen mustard was cytotoxic to lymphoid malignancies. The initial enthusiasm was soon tempered by the observation that most resp...

    G. Stoter, C. J. Rodenburg in Combination Therapy in Urological Malignancy (1989)

  9. No Access

    Chapter

    Chemotherapy in Disseminated Testicular Cancer

    Testicular germ cell tumours can be divided into seminomas and non-seminomas. Seminomas are radiosensitive and approximately 90% can be cured with radiotherapy since, in the majority of cases, the disease is l...

    C. J. Rodenburg, G. Stoter in Combination Therapy in Urological Malignancy (1989)

  10. No Access

    Article

    Chemotherapy in advanced ovarian cancer

    The chemotherapy of advanced ovarian cancer is reviewed. Treatment with single agents results in low remission rates and few complete remissions. The results have been improved with modern combination chemothe...

    C. J. Rodenburg, F. J. Cleton in Journal of Cancer Research and Clinical Oncology (1984)